We are live on ! Find out more
CMRX

Chimerix, Inc.

Delisted

CMRX was delisted on the 17th of April, 2025.

94 hedge funds and large institutions have $96M invested in Chimerix, Inc. in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

11% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 27

6% more funds holding

Funds holding: 8994 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

35% less capital invested

Capital invested by funds: $148M → $96M (-$51.5M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $51K

Holders
94
Holders Change
+5
Holders Change %
+5.62%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
30
Reduced
27
Closed
10
Calls
Puts
$51K
Net Calls
-$51K
Net Calls Change
+$11K
Name Holding Trade Value Shares
Change
Change in
Stake
ACH
1
ArrowMark Colorado Holdings
Colorado
$12.1M +$2.42M +722,753 +18%
RG
2
Redmile Group
California
$9.16M -$87.4K -26,100 -0.7%
BlackRock
3
BlackRock
New York
$8.49M -$1.36M -406,518 -11%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$6.71M +$189K +56,347 +2%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$6.26M -$4.8M -1,434,853 -37%
Morgan Stanley
6
Morgan Stanley
New York
$5.49M +$321K +95,985 +5%
OM
7
Opaleye Management
Massachusetts
$5.19M +$2.8M +835,000 +70%
NLVP
8
New Leaf Venture Partners
New York
$3.47M +$1.17M +350,000 +35%
AG
9
Artal Group
Luxembourg
$2.57M
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$2.57M
Vanguard Group
11
Vanguard Group
Pennsylvania
$2.48M -$3.85M -1,149,327 -54%
State Street
12
State Street
Massachusetts
$2.28M -$101K -30,115 -3%
Man Group
13
Man Group
United Kingdom
$2.13M -$289K -86,400 -9%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$1.7M +$348K +103,799 +19%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.66M +$384K +114,702 +22%
Renaissance Technologies
16
Renaissance Technologies
New York
$1.45M +$584K +174,464 +45%
Northern Trust
17
Northern Trust
Illinois
$1.28M -$4.13K -1,233 -0.2%
RC
18
RBF Capital
California
$1.22M +$1.59M +474,578 New
AC
19
Aisling Capital
New York
$1.22M
Victory Capital Management
20
Victory Capital Management
Texas
$1.18M +$602K +179,910 +65%
PPA
21
Parametric Portfolio Associates
Washington
$1.03M +$570K +170,218 +74%
Millennium Management
22
Millennium Management
New York
$837K +$221K +66,014 +25%
Axa
23
Axa
France
$820K
Two Sigma Investments
24
Two Sigma Investments
New York
$793K +$357K +106,750 +53%
Connor, Clark & Lunn Investment Management (CC&L)
25
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$780K +$37K +11,050 +4%

CMRX Hedge Fund Activity: Q4 2018 in Review

94 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q4 2018, worth a combined $96M — down 35% from $148M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CMRX positions and 10 closed out — a net gain of 5 holders — while 30 added to existing stakes and 27 trimmed.

The largest buyer was Opaleye Management, adding an estimated $2.8M. The largest seller was Armistice Capital, exiting entirely with an estimated $5.06M sold.

  • 94 institutional investors held Chimerix, Inc. (CMRX) as of Q4 2018, up from 89 in Q3 2018.
  • Funds reported $96M of Chimerix, Inc. stock for Q4 2018, down 35% quarter-over-quarter.
  • 15 funds opened new Chimerix, Inc. positions in Q4 2018 and 10 closed out, a net change of +5 holders.
  • The largest Chimerix, Inc. buyer in Q4 2018 was Opaleye Management, an estimated $2.8M added.
  • The largest Chimerix, Inc. seller in Q4 2018 was Armistice Capital, an estimated $5.06M sold.

Based on aggregated 13F filings for Q4 2018.